trending Market Intelligence /marketintelligence/en/news-insights/trending/-4alJFhpgPzWg2D38_UmYQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Protagonist Therapeutics names board member

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Protagonist Therapeutics names board member

Protagonist Therapeutics Inc. appointed Bryan Giraudo to its board.

Giraudo also serves as CFO of Gossamer Bio Inc. Previously, he worked at Leerink Partners as senior managing director, in charge of western North America and Asia biotechnology and pharmaceutical relationships.

Protagonist Therapeutics is a Newark, Calif.-based biopharmaceutical company, whose product pipeline includes therapies for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.